[HTML][HTML] Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
Background Since the emergence of COVID-19 there have been increasing global concerns
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
M Tang, B Daniels, M Aslam… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Since the emergence of COVID-19 there have been increasing global concerns
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
[HTML][HTML] Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
M Tang, B Daniels, M Aslam, A Schaffer… - The Lancet Regional …, 2021 - ncbi.nlm.nih.gov
Background Since the emergence of COVID-19 there have been increasing global concerns
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
[PDF][PDF] The Lancet Regional Health-Western Pacific
M Tang, B Daniels, M Aslam, A Schaffer, SA Pearson - 2021 - nova.newcastle.edu.au
abstract Background: Since the emergence of COVID-19 there have been increasing global
concerns about delays and/or discontinuations in cancer care. However, it is unclear to what …
concerns about delays and/or discontinuations in cancer care. However, it is unclear to what …
Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study.
M Tang, B Daniels, M Aslam, A Schaffer… - The Lancet Regional …, 2021 - europepmc.org
Background Since the emergence of COVID-19 there have been increasing global concerns
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
[HTML][HTML] Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
M Tang, B Daniels, M Aslam, A Schaffer… - The Lancet Regional …, 2021 - Elsevier
Background Since the emergence of COVID-19 there have been increasing global concerns
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
about delays and/or discontinuations in cancer care. However, it is unclear to what extent …
Changes in Systemic Cancer Therapy in Australia During the COVID-19 Pandemic: a Population-Based Study
M Tang, B Daniels, M Aslam, A Schaffer, SA Pearson - cbdrh.med.unsw.edu.au
• March to December 2020: no decrease in antineoplastic dispensing• March 2020:
temporary increase in dispensing (39/100,000 population) and initiation of all antineoplastic …
temporary increase in dispensing (39/100,000 population) and initiation of all antineoplastic …
Changes in Systemic Cancer Therapy in Australia During the COVID-19 Pandemic: a Population-Based Study
M Tang, B Daniels, M Aslam, A Schaffer, SA Pearson - unsw.edu.au
• March to December 2020: no decrease in antineoplastic dispensing• March 2020:
temporary increase in dispensing (39/100,000 population) and initiation of all antineoplastic …
temporary increase in dispensing (39/100,000 population) and initiation of all antineoplastic …
Changes in Systemic Cancer Therapy in Australia During the COVID-19 Pandemic: a Population-Based Study
M Tang, B Daniels, M Aslam, A Schaffer, SA Pearson - unsw.edu.au
• March to December 2020: no decrease in antineoplastic dispensing• March 2020:
temporary increase in dispensing (39/100,000 population) and initiation of all antineoplastic …
temporary increase in dispensing (39/100,000 population) and initiation of all antineoplastic …